Animal models for drug discovery in dystonia (Q38088284)

28 August 2017

title

Animal models for drug discovery in dystonia (English)

1 reference

28 August 2017

1 reference

7

Mark R Cookson

1 reference

28 August 2017

Xandra O. Breakefield

8

object named as

Xandra O Breakefield

1 reference

28 August 2017

Kim A Caldwell

5

1 reference

ORCID Public Data File 2021

Guy A Caldwell

4

object named as

Guy A Caldwell

1 reference

28 August 2017

Ha Jinnah

1

1 reference

28 August 2017

Angelika Richter

2

1 reference

28 August 2017

Jonathon W Mink

3

1 reference

28 August 2017

Pedro Gonzalez-Alegre

6

1 reference

28 August 2017

Mahlon R Delong

9

1 reference

28 August 2017

Ellen J Hess

10

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

Expert Opinion on Drug Discovery

28 August 2017

published in

1 reference

28 August 2017

volume

3

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

83-97

1 reference

The genetics of primary dystonias and related disorders

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Classification and genetics of dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Dystonia and parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Classification and definition of disorders causing hypertonia in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Dyskinetic cerebral palsy. I. Clinical categories, associated neurological abnormalities and incidences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Intrathecal baclofen for generalized dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Intrathecal baclofen for dystonia: benefits and complications during six years of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Rodent models for dystonia research: characteristics, evaluation, and utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

The sz mutant hamster: a genetic model of epilepsy or of paroxysmal dystonia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Pathology of idiopathic dystonia: findings from genetic animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Absence epilepsy in tottering mutant mice is associated with calcium channel defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Single tottering mutations responsible for the neuropathic phenotype of the P-type calcium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Cerebellar circuitry is activated during convulsive episodes in the tottering (tg/tg) mutant mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Tottering mouse motor dysfunction is abolished on the Purkinje cell degeneration (pcd) mutant background

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Selective putaminal excitotoxic lesions in non-human primates model the movement disorder of Huntington disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Experimental spasmodic torticollis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Frontal torticollis (head tilt) induced by electrolytic lesion and kainic acid injection in monkeys and cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Midbrain control of three-dimensional head orientation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

The anatomical basis of symptomatic hemidystonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced acute transient dystonia in monkeys associated with low striatal dopamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Induction of chorea and dystonia in parkinsonian primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Dystonia is predictive of subsequent altered dopaminergic responsiveness in a chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine+3-nitropropionic acid model of striatonigral degeneration in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Invertebrate animal models of diseases as screening tools in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Animal models of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Molecular pathophysiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

The biochemistry of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Lost in translation: treatment trials in the SOD1 mouse and in human ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

The value of animal models for drug development in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Neuroprotection for ischemic stroke: two decades of success and failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Animal models of stroke: do they have value for discovering neuroprotective agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

1,026 experimental treatments in acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Molecular targets versus models for new antiepileptic drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Suppression of polyglutamine-induced protein aggregation in Caenorhabditis elegans by torsin proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Antidystonic effects of Kv7 (KCNQ) channel openers in the dt sz mutant, an animal model of primary paroxysmal dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Two novel CACNA1A gene mutations associated with episodic ataxia type 2 and interictal dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Abnormal motor behavior and vestibular dysfunction in the stargazer mouse mutant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Task-specific hand dystonia: can too much plasticity be bad for you?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Molecular pathogenesis of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

Dopamine release is impaired in a mouse model of DYT1 dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.83

21 January 2018

Identifiers

DOI

10.1517/17460441.3.1.83

1 reference

28 August 2017

1 reference